In the previous post a scientist confirms that these vaccines could alter human DNA
Stabiliser in vaccines – polyethylene glycol (PEG) – causes allergic and autoimmune responses
In an article on Global Research on 8 March 2021, Mike Whitney notes that the vaccine made by Pfizer contains polyethylene glycol to “stabilise” it. In a 10 December 2020 article on Reuters, it was reported in an article titled: “UK issues anaphylaxis warning on Pfizer vaccine after adverse reactions,” that doctors were warning “that those who had had anaphylactic reactions in the past, and those prone to allergic reactions, should rather not take the vaccine, since this could lead to severe or even potentially life-threatening adverse events. They acknowledge that this reaction could be caused by the inclusion of polyethylene glycol as an ingredient. However, the overall the benefits still outweigh the risks, according to doctors.”
Robert F Kennedy Jr. had already warned the US FDA about the risk of allergic reactions to PEG months previously, and Whitney writes: “Recently, Dr Peter Marks of the FDA admitted that the population was sensitised by PEG-containing pharmaceutical preparations (that include other vaccines/injections)”.
Anaphylactic reactions
Anaphylaxis (a term coined by Charles Richet, who was awarded a Nobel Prize for this work) is the opposite of protection (which a vaccine is supposed to confer), “where an organism becomes hypersensitive and thus susceptible rather than protected”. When the body perceives an antigen to be foreign – a toxic intruder – it will thus attack; thereby the body turns on itself, with the possible outcome of autoimmune diseases that can lead to death. Based on many confirmatory experiments, Richet found that subjects were most sensitised and likely to suffer an anaphylactic reaction after the second injection, if administered after a three- to four-week incubation period following the first injection.
In January 2021, the UK Health Service announced the extension of the timeframe between the first and second Pfizer vaccine from three to 12 weeks, a timeframe the company admits is “untested”, which is likely to lead to more anaphylactic reactions. Reactions can also be triggered by adjuvants, such as mercury and aluminium, as well as other items, such as foetal stem cells that vaccines sometimes contain, and thus people who have had flu shots with the same adjuvants could have an anaphylactic reaction to these injections.
Potential adverse effects on the brain
Whitney cites a video interview, where journalist and founder of The Highwire, Del Bigtree, speaks to British Columbia neuroscientist Chris Shaw about his concerns regarding the potential adverse impacts on the brain by the mRNA vaccines, on 14 January 2021. After Shaw assessed the adverse effects found in phase three trials of Pfizer and Moderna mRNA vaccines on humans, he looked at previous animal studies by Moderna, of a mRNA vaccine against a different virus, which provided data on testing nRNA vaccines in general, from 2012. In those experiments, the lipid coating of the mRNA virus was made from PEG (as is the lipid coating of current vaccines, discussed above), which was found in the brain, among other places, indicating that it did not break down as fast as it should have. What impacts this could have on the brain are cause for concern and unknown, Shaw told Bigtree.
Bell’s Palsy in vaccinated cohorts
Whitey reports that another adverse event scientists have raised concerns about is Bell’s Palsy, after it was observed in a Pfizer trial that the “incidence of Bell’s palsy in the vaccine arms is between 3.5 and 7 times higher than would be expected in the general population. This finding signals a potential safety phenomenon and suggests inaccurate reporting of basic epidemiological context to the public”.
Vaccine adverse events in the US: Disjuncture between headlines and reporting
On January 6, 2021 there were headlines in the US to the effect that while over five million Americans had been vaccinated, there were only around 29 cases of confirmed adverse reactions, as reported by the Business Insider. However, a very different picture emerges from the reports filed between 14 December 2020 and 29 Jan 2021 on the US CDC’s Vaccine Adverse Event Reporting System (VAERS), following COVID-19 vaccinations, as reported by Children’s Health Defense. In this time, 501 deaths had been reported, as a subset of 11,249 total adverse events following COVID-19 vaccinations.
While reports submitted to VAERS require further investigation before confirmation can be made that an adverse event is linked to a vaccine, it is important to note that a 2010 US Federal study estimated the reported adverse events to be much, much lower than the actual events – even as low as 1% of actual injuries.
A more recent Children’s Health Defense article, on 9 April, 2021, notes “that between Dec. 14, 2020 and April 1, a total of 56,869 total adverse events were reported to VAERS, including 2,342 deaths — an increase of 93 over the previous week — and 7,971 serious injuries, up 245 over the same time period. The numbers of reported deaths and adverse events is growing.
Circuitous route to access records of adverse events in the UK
In the UK, it is immensely difficult to reach the website that records the adverse events, as Brian Gerrish of UK Column demonstrates in a news broadcast on 31 April 2021. He shares the recording of speaking to a National Health Service (NHS) call centre operator, who was unable to provide any information regarding adverse events. Then he demonstrates how finding the website that houses the records requires tenacity, with links placed in indirectly related sections and several clicks needed. It appears the health officials are trying to stop people from looking at this information. In South African, Nick Hudson of PANDA has raised concerns regarding what processes are even in place to record adverse events, never mind whether these records will be publicly available.
Vaccine manufacturers bear no liability for injury or death caused by vaccines
On the UK Column, on 2 Feb 2021, Iain Davis writes that in the UK the
“MHRA informed the Financial Times that the COVID–19 vaccines had undergone rigorous testing. This was a disingenuous statement. None of the COVID–19 vaccine are close to completing any clinical trials. They are not licensed by the MHRA and do not have marketing authorisation. They have been distributed in the UK thanks to legislative changes to Regulation 174 of the Human Medicine Regulations 2012 (as amended). These changes included the removal of all liability from manufacturers and distributors.”
In Vaccines Revealed Episode 4, Dr Brian Hooker also reminds us that the current vaccines are not “approved” by the US FDA in the “traditional sense” but have rather been given “emergency use authorisation,” and that the limited amount of testing done has yielded a high frequency of adverse events, reports of which are highly censored or completely suppressed. This limits the liability of vaccine manufactures, and even private insurers are not taking on liability of injuries caused by vaccines due to them being considered experimental treatment.
Uninformed consent
Since people are not given sufficient information for an accurate risk-benefit assessment, their consent to be vaccinated cannot be considered informed. And since these vaccines are approved for emergency use only, manufacturers and health insurers are exempt from liability stemming from adverse events.
Rollout of COVID-19 vaccines and resultant spike in death in elderly
In the UK, the rollout of vaccines in care homes coincided in a spike in deaths of over 80s. Disturbingly, the possibility that the vaccines could be the cause is being denied or ignored, when it should be urgently investigated, comments Iain Davis in the UK Column on 2 Feb 2021 in, “Why Is There A Correlation Between The Vaccine Rollout And Increased COVID–19 Mortality?”
He analyses the statistics from four phases in the UK: the period of the hard lockdown, the summer and then autumn months, and then the winter. The entire analysis is worth reading but specifically regarding his analysis of the deaths during the first vaccine rollout, mainly in care homes (from 20 December 2020 to the end of January 2021). He writes: “[D]espite continued falling mortality rates in early December, the new COVID–19 variants suddenly changed behaviour. Hospitalisation rates increased by more than 8% and the mortality risk shot up by over 31%. […] Harsher winter conditions are expected to account for more numbers of hospitalisations and deaths, but not to fundamentally change the characteristics of the resultant disease,” leading him to theorise that the vaccines were a causative factor.
The next post examines the issues of variants and the vaccine push.